Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Preoperative botulinum toxin test injections before muscle lengthening in cerebral palsy.

Rutz E, Hofmann E, Brunner R.

J Orthop Sci. 2010 Sep;15(5):647-53. doi: 10.1007/s00776-010-1509-6. Epub 2010 Oct 16.

PMID:
20953926
2.

Distal rectus femoris intramuscular lengthening for the correction of stiff-knee gait in children with cerebral palsy.

Cruz AI, Ounpuu S, Deluca PA.

J Pediatr Orthop. 2011 Jul-Aug;31(5):541-7. doi: 10.1097/BPO.0b013e31821f818d.

PMID:
21654463
3.

A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures.

Desloovere K, Molenaers G, Jonkers I, De Cat J, De Borre L, Nijs J, Eyssen M, Pauwels P, De Cock P.

Eur J Neurol. 2001 Nov;8 Suppl 5:75-87.

PMID:
11851736
4.

The influence of botulinum toxin A injections into the calf muscles on genu recurvatum in children with cerebral palsy.

Klotz MC, Wolf SI, Heitzmann D, Gantz S, Braatz F, Dreher T.

Clin Orthop Relat Res. 2013 Jul;471(7):2327-32. doi: 10.1007/s11999-013-2897-7. Epub 2013 Mar 6.

5.

Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy.

Wong AM, Chen CL, Chen CP, Chou SW, Chung CY, Chen MJ.

Am J Phys Med Rehabil. 2004 Apr;83(4):284-91.

PMID:
15024330
6.

Ankle dorsiflexor function after plantar flexor surgery in children with cerebral palsy.

Davids JR, Rogozinski BM, Hardin JW, Davis RB.

J Bone Joint Surg Am. 2011 Dec 7;93(23):e1381-7. doi: 10.2106/JBJS.K.00239.

PMID:
22159860
7.

Long-term effects after conversion of biarticular to monoarticular muscles compared with musculotendinous lengthening in children with spastic diplegia.

Dreher T, Vegvári D, Wolf SL, Klotz M, Müller S, Metaxiotis D, Wenz W, Döderlein L, Braatz F.

Gait Posture. 2013 Mar;37(3):430-5. doi: 10.1016/j.gaitpost.2012.08.020. Epub 2012 Sep 25.

PMID:
23018029
8.

Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences.

Molenaers G, Desloovere K, De Cat J, Jonkers I, De Borre L, Pauwels P, Nijs J, Fabry G, De Cock P.

Eur J Neurol. 2001 Nov;8 Suppl 5:88-97.

PMID:
11851737
9.

Efficacy and safety of serial injections of botulinum toxin A in children with spastic cerebral palsy.

Wang YJ, Gao BQ.

World J Pediatr. 2013 Nov;9(4):342-5. doi: 10.1007/s12519-013-0442-0. Epub 2013 Nov 14.

PMID:
24235067
10.

Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.

Linder M, Schindler G, Michaelis U, Stein S, Kirschner J, Mall V, Berweck S, Korinthenberg R, Heinen F.

Eur J Neurol. 2001 Nov;8 Suppl 5:120-6.

PMID:
11851740
11.

Kinematic and kinetic outcomes after identical multilevel soft tissue surgery in children with cerebral palsy.

Adolfsen SE, Ounpuu S, Bell KJ, DeLuca PA.

J Pediatr Orthop. 2007 Sep;27(6):658-67.

PMID:
17717467
12.

Use of gait parameters to predict the effectiveness of botulinum toxin injection in the spastic rectus femoris muscle of stroke patients with stiff knee gait.

Roche N, Boudarham J, Hardy A, Bonnyaud C, Bensmail B.

Eur J Phys Rehabil Med. 2015 Aug;51(4):361-70. Epub 2014 Sep 12.

13.

[Botulinum toxin type A in the treatment plan for cerebral palsy].

Strobl W.

Wien Klin Wochenschr. 2001;113 Suppl 4:30-5. Review. German.

PMID:
15506050
14.

The effects of muscle-tendon surgery on dynamic electromyographic patterns and muscle tone in children with cerebral palsy.

Dreher T, Brunner R, Vegvari D, Heitzmann D, Gantz S, Maier MW, Braatz F, Wolf SI.

Gait Posture. 2013 Jun;38(2):215-20. doi: 10.1016/j.gaitpost.2012.11.013. Epub 2012 Dec 8.

PMID:
23228624
15.

Can persistent drop foot after calf muscle lengthening be predicted preoperatively?

Lofterød B, Fosdahl MA, Terjesen T.

J Foot Ankle Surg. 2009 Nov-Dec;48(6):631-6. doi: 10.1053/j.jfas.2009.07.001. Epub 2009 Sep 1.

PMID:
19857817
16.
17.

Development of knee function after hamstring lengthening as a part of multilevel surgery in children with spastic diplegia: a long-term outcome study.

Dreher T, Vegvari D, Wolf SI, Geisbüsch A, Gantz S, Wenz W, Braatz F.

J Bone Joint Surg Am. 2012 Jan 18;94(2):121-30. doi: 10.2106/JBJS.J.00890.

PMID:
22257998
18.

Correction of severe crouch gait in patients with spastic diplegia with use of multilevel orthopaedic surgery.

Rodda JM, Graham HK, Nattrass GR, Galea MP, Baker R, Wolfe R.

J Bone Joint Surg Am. 2006 Dec;88(12):2653-64.

PMID:
17142416
19.

A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.

Chaléat-Valayer E, Parratte B, Colin C, Denis A, Oudin S, Bérard C, Bernard JC, Bourg V, Deleplanque B, Dulieu I, Evrard P, Filipetti P, Flurin V, Gallien P, Héron-Long B, Hodgkinson I, Husson I, Jaisson-Hot I, Maupas E, Meurin F, Monnier G, Pérennou D, Pialoux B, Quentin V, Moreau MS, Schneider M, Yelnik A, Marque P.

Eur J Paediatr Neurol. 2011 Sep;15(5):439-48. doi: 10.1016/j.ejpn.2010.04.006. Epub 2011 Jul 13.

PMID:
21745754
20.

Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.

Koman LA, Brashear A, Rosenfeld S, Chambers H, Russman B, Rang M, Root L, Ferrari E, Garcia de Yebenes Prous J, Smith BP, Turkel C, Walcott JM, Molloy PT.

Pediatrics. 2001 Nov;108(5):1062-71.

PMID:
11694682

Supplemental Content

Support Center